KR19990076637A - 비타민 d 유사체를 함유하는 제약 조성물 - Google Patents
비타민 d 유사체를 함유하는 제약 조성물 Download PDFInfo
- Publication number
- KR19990076637A KR19990076637A KR1019980704745A KR19980704745A KR19990076637A KR 19990076637 A KR19990076637 A KR 19990076637A KR 1019980704745 A KR1019980704745 A KR 1019980704745A KR 19980704745 A KR19980704745 A KR 19980704745A KR 19990076637 A KR19990076637 A KR 19990076637A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- vitamin
- formula
- hydrogen atom
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19549243A DE19549243A1 (de) | 1995-12-21 | 1995-12-21 | Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga |
| DE19549243.9 | 1995-12-21 | ||
| PCT/EP1996/005856 WO1997023242A1 (de) | 1995-12-21 | 1996-12-20 | Pharmazeutische präparate mit vitamin d-analoga |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990076637A true KR19990076637A (ko) | 1999-10-15 |
Family
ID=7781710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019980704745A KR19990076637A (ko) | 1995-12-21 | 1996-12-20 | 비타민 d 유사체를 함유하는 제약 조성물 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0869819A1 (hu) |
| JP (1) | JP2000502733A (hu) |
| KR (1) | KR19990076637A (hu) |
| CN (1) | CN1207687A (hu) |
| AU (1) | AU1306997A (hu) |
| CA (1) | CA2241205A1 (hu) |
| DE (1) | DE19549243A1 (hu) |
| HU (1) | HUP9903935A3 (hu) |
| IL (1) | IL125020A0 (hu) |
| IS (1) | IS4774A (hu) |
| NO (1) | NO982874L (hu) |
| WO (1) | WO1997023242A1 (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
| US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
| US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
| GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| DE102005017775A1 (de) * | 2005-04-13 | 2006-10-19 | Schering Ag | Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins |
| LT1993559T (lt) | 2006-02-03 | 2016-11-10 | Opko Renal, Llc | Vitamino d nepakankamumo ir deficito gydymas su 25-hidroksivitaminu d2 ir 25-hidroksivitaminu d3 |
| PL2037936T3 (pl) | 2006-06-21 | 2015-04-30 | Opko Renal Llc | Sposób leczenia i zapobiegania wtórnej nadczynności przytarczyc |
| KR100822133B1 (ko) * | 2006-11-06 | 2008-04-15 | 한미약품 주식회사 | 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제 |
| KR101495578B1 (ko) | 2007-04-25 | 2015-02-25 | 사이토크로마 인코포레이티드 | 비타민 ｄ 부족 및 결핍의 치료 방법 |
| US20100144684A1 (en) | 2007-04-25 | 2010-06-10 | Proventiv Therapeutics, Inc. | Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease |
| JP5501956B2 (ja) | 2007-04-25 | 2014-05-28 | シトクロマ インコーポレイテッド | ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物 |
| CA2684778C (en) | 2007-04-25 | 2017-09-05 | Cytochroma Inc. | Methods and compounds for vitamin d therapy |
| CN106853250A (zh) | 2008-04-02 | 2017-06-16 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
| CN105796530A (zh) | 2010-03-29 | 2016-07-27 | 赛特克罗公司 | 用于降低甲状旁腺水平的方法和组合物 |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| CN114681468A (zh) | 2014-08-07 | 2022-07-01 | 欧普科爱尔兰环球控股有限公司 | 利用25-羟基维生素d的辅助疗法 |
| CR20180510A (es) | 2016-03-28 | 2019-05-15 | Opko Ireland Global Holdings Ltd | Método de tratamiento con vitamina d |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177586B (en) * | 1978-12-19 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | New process for preparing stable inclusion complexes of vitamine d with cyclodextrin |
| JPS5910562A (ja) * | 1982-07-07 | 1984-01-20 | Teijin Ltd | プレ−１α−ヒドロキシコレカルシフエロ−ル類の製造法 |
| JPS5936656A (ja) * | 1982-08-23 | 1984-02-28 | Teijin Ltd | 新規包接化合物及びそれを活性成分とする薬剤 |
| JPS60120812A (ja) * | 1983-12-02 | 1985-06-28 | Teijin Ltd | 糖尿病性骨減少症治療剤 |
| ATE104554T1 (de) * | 1990-01-10 | 1994-05-15 | Hoffmann La Roche | Topische praeparate. |
| IL107185A (en) * | 1992-10-06 | 1998-02-22 | Schering Ag | History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them |
-
1995
- 1995-12-21 DE DE19549243A patent/DE19549243A1/de not_active Withdrawn
-
1996
- 1996-12-20 KR KR1019980704745A patent/KR19990076637A/ko not_active Application Discontinuation
- 1996-12-20 WO PCT/EP1996/005856 patent/WO1997023242A1/de not_active Application Discontinuation
- 1996-12-20 HU HU9903935A patent/HUP9903935A3/hu unknown
- 1996-12-20 CN CN96199734A patent/CN1207687A/zh active Pending
- 1996-12-20 CA CA002241205A patent/CA2241205A1/en not_active Abandoned
- 1996-12-20 AU AU13069/97A patent/AU1306997A/en not_active Abandoned
- 1996-12-20 JP JP9523335A patent/JP2000502733A/ja active Pending
- 1996-12-20 EP EP96944669A patent/EP0869819A1/de not_active Withdrawn
- 1996-12-20 IL IL12502096A patent/IL125020A0/xx unknown
-
1998
- 1998-06-15 IS IS4774A patent/IS4774A/is unknown
- 1998-06-19 NO NO982874A patent/NO982874L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1306997A (en) | 1997-07-17 |
| CN1207687A (zh) | 1999-02-10 |
| CA2241205A1 (en) | 1997-07-03 |
| IS4774A (is) | 1998-06-15 |
| HUP9903935A3 (en) | 2000-05-29 |
| NO982874D0 (no) | 1998-06-19 |
| WO1997023242A1 (de) | 1997-07-03 |
| EP0869819A1 (de) | 1998-10-14 |
| NO982874L (no) | 1998-08-20 |
| DE19549243A1 (de) | 1997-06-26 |
| HUP9903935A2 (hu) | 2000-03-28 |
| JP2000502733A (ja) | 2000-03-07 |
| IL125020A0 (en) | 1999-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR19990076637A (ko) | 비타민 d 유사체를 함유하는 제약 조성물 | |
| Cal et al. | Use of cyclodextrins in topical formulations: Practical aspects | |
| EP0585170B1 (fr) | Composition pour le traitement de l'acné contenant au moins un dérivé d'acide salicylique | |
| JP4764004B2 (ja) | アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤 | |
| US20070093448A1 (en) | Complexes that consist of vitamin D compounds or analogs thereof with a 5Z,7E,10(19)-triene system and methylated derivatives of beta-cyclodextrin | |
| US20170274097A1 (en) | Compositions containing cyclodextrin-based metal organic frameworks | |
| FR2808691A1 (fr) | Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine | |
| KR100708360B1 (ko) | 라스-파르네실트란스퍼라제 억제제와술포부틸에테르-7-β-시클로덱스트린 또는2-히드록시프로필-β-시클로덱스트린과의 착물 및 방법 | |
| JP2833711B2 (ja) | 尋常性座瘡を局所的に処置する方法 | |
| NO134373B (hu) | ||
| EP2335704A1 (fr) | Composition pharmaceutique comprenant un sel de strontium, de la vitamine D et une cyclodextrine | |
| EP1694660B1 (en) | Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions | |
| Duchêne et al. | Cyclodextrins in cosmetics | |
| EP1951199A2 (fr) | Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition. | |
| JP2007509137A (ja) | 溶解性及び生体内利用率が改善されたチオウレア誘導体含有の医薬用組成物 | |
| WO1986004504A1 (en) | 9-halogen prostaglandine clathrates and utilization thereof as drugs | |
| KR19990021864A (ko) | 탈모증 치료 및 예방을 위한 국소 외용제 | |
| Bodor et al. | Soft drugs 18. Oral and rectal delivery of loteprednol etabonate, a novel soft corticosteroid, in rats—for safer treatment of gastrointestinal inflammation | |
| AU727291B2 (en) | Therapeutic and cosmetic compositions, their use and method for the preparation thereof | |
| FR2588474A1 (fr) | Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste | |
| JPH0348655A (ja) | プロスタグランジンｄ↓２類の安定化 | |
| EP0447015A1 (de) | 9-Halogenprostaglandin-Clatrathe und ihre Verwendung als Arzneimittel | |
| WO2008018592A1 (fr) | Préparation externe comprenant un dérivé de la prostaglandine | |
| JP2889864B2 (ja) | 結晶態のビタミンｄ誘導体 | |
| Bodor et al. | Soft Drugs 18. Oral and Rectal Delivery of Loteprednol Etabonate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |